title: Medication to prevent breast cancer--too much to swallow?
abstract: Selective oestrogen receptor modulators effectively reduce breast cancer in women at moderate to high risk, so why aren't they being discussed routinely?
authors.affiliation: Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC.
authors.forename: Sandra L
authors.initials: SL
authors.lastname: Harvey
authors.forename: Jane E
authors.initials: JE
authors.lastname: Francis
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: McBride
authors.forename: James F
authors.initials: JF
authors.lastname: Bishop
authors.forename: Kelly-Anne
authors.initials: KA
authors.lastname: Phillips
mesh_terms: D001315:Australia; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D020845:Selective Estrogen Receptor Modulators